Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Debt Repayment

Cash used to repay borrowings during the period.

Orthofix Medical Inc.NASDAQ: OFIX

Debt Repayment · Q1 FY2026 · quarter ended Mar 2026

Debt repayment turns positive

Q1 FY2026 debt repayment was $63.99M, compared with -$188K a year earlier. Trailing-twelve-month debt repayment was $63.42M. Over 3 fiscal years it compounded at -33.5% a year.

Context

  • Debt repayment amounted to 0.1% of revenue in FY2025, down 6.7 pp from a year earlier.
  • Debt repayment increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly debt repayment holds near $63.99M or moves back toward the trailing-twelve-month quarterly average of $15.86M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$63.99M+32769.7% QoQ
Last fiscal yearDec 2025
-$762K-101.4% YoY
LTMMar 2026
$63.42M+115.9% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+34139.4%——
1 year-101.4%——
3-year CAGR-33.5%——
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(762K) USD
Year-over-year change
-101.4%

Debt Repayment vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 debt repayment of $63.42M is the 2nd largest of the 11 companies compared; the peer median is $0.
  • Its year-over-year change of +115.9% is the 2nd highest of 8, against a peer median of -66.5%.
  • Debt repayment amounts to 7.7% of revenue for OFIX, versus a peer median of 0.0%.
OFIX Competitors Peer median
Debt Repayment for OFIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VREXVarex Imaging CorporationLTM Apr 2026$224M -279.2%+36.6%26.1%
OFIXOrthofix Medical Inc.LTM Mar 2026$63.42M +115.9%-33.5%7.7%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$54.91M +300.6%-1.9%13.1%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$24.47M -66.5%——
AVNSAvanos Medical, Inc.LTM Mar 2026$9.4M -86.4%—1.3%
ABSIAbsci CorporationLTM Mar 2026$2.85M -20.2%—155.1%
BFLYButterfly Network, Inc.LTM Mar 2026$0 ——0.0%
SIBNSI-BONE, Inc.LTM Mar 2026$0 ——0.0%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$0 -100.0%—0.0%
LABStandard BioTools Inc.LTM Mar 2026$0 +100.0%—0.0%
DRIODarioHealth Corp.LTM Mar 2026$0 —-80.2%0.0%
Peer median (excluding OFIX) $0-66.5%-1.9%0.0%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Depreciation & Amortization33.1M32.08M60.6M75.96M83.26M
Deferred Income Tax24.48M314K579K1.88M223K
Stock-Based Compensation15.43M18.44M35.71M32.46M28.69M
Change in Working Capital(18.1M)(29.24M)(53.96M)(19.25M)(21.5M)
Accounts Receivables(7.05M)(6.74M)(10.41M)(9.53M)(1.58M)
Inventory619K(18.13M)(58.05M)(5.55M)(10.75M)
Accounts Payables4.25M2.28M8.64M(5.57M)2.6M
Other Working Capital(15.93M)(6.65M)5.86M1.39M(11.77M)
Other Non-Cash Items1.95M(13.39M)62.72M60.74M54.84M
Operating Cash Flow18.48M(11.54M)(45.75M)25.79M33.35M
Capital Expenditures(19.59M)(23.16M)(62.05M)(34.88M)(34.63M)
Acquisitions (Net)0(1.5M)29.42M00
Purchases of Investments(2.17M)0000
Sales of Investments0126K07.4M0
Other Investing Activities(1.25M)(1.37M)(500K)(100K)(34.6M)
Investing Cash Flow(23.01M)(24.53M)(33.13M)(27.58M)(34.6M)
Debt Repayment(537K)(2.59M)67.95M54.39M(762K)
Common Stock Issued8.82M4.34M5.13M6.26M5.93M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(11.91M)(1.82M)(7.75M)(9.94M)(5.95M)
Financing Cash Flow(3.62M)(78K)65.32M50.71M(786K)
Effect of Forex Changes(815K)(997K)619K(938K)1.41M
Net Change in Cash(8.97M)(37.15M)(12.94M)47.98M(623K)
Free Cash Flow(1.12M)(34.7M)(107.8M)(9.09M)(1.28M)

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.